Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

Henrik Watz, Kay Tetzlaff, Emiel F. M. Wouters, Anne Kirsten, Helgo Magnussen, Roberto Rodriguez-Roisin, Claus Vogelmeier, Leonardo M. Fabbri, Pascal Chanez, Ronald Dahl, Bernd Disse, Helen Finnigan, Peter M. A. Calverley

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)
Original languageEnglish
Pages (from-to)390-398
JournalThe Lancet Respiratory medicine
Volume4
Issue number5
DOIs
Publication statusPublished - May 2016

Cite this

Watz, H., Tetzlaff, K., Wouters, E. F. M., Kirsten, A., Magnussen, H., Rodriguez-Roisin, R., Vogelmeier, C., Fabbri, L. M., Chanez, P., Dahl, R., Disse, B., Finnigan, H., & Calverley, P. M. A. (2016). Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. The Lancet Respiratory medicine, 4(5), 390-398. https://doi.org/10.1016/S2213-2600(16)00100-4